» Authors » Christina Alamara

Christina Alamara

Explore the profile of Christina Alamara including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 70
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stergiou G, Bountzona I, Alamara C, Vazeou A, Kollias A, Ntineri A
Hypertension . 2021 Jan; 77(3):993-1000. PMID: 33423526
This study aimed to evaluate the reproducibility of office (OBP), ambulatory (ABP), and home blood pressure (HBP) measurements in children and adolescents, and their implications in diagnosing hypertension in clinical...
2.
Tourkantonis I, Makrilia N, Ralli M, Alamara C, Nikolaidis I, Tsimpoukis S, et al.
Am J Clin Oncol . 2010 Feb; 34(1):38-42. PMID: 20142722
Objective: The combinations of cisplatin-pemetrexed and cisplatin-gemcitabine are considered the standard systemic therapy for malignant pleural mesothelioma (MPM), which is a rapidly progressive tumor. The purpose of the present study...
3.
Chatzidarellis E, Makrilia N, Giza L, Georgiadis E, Alamara C, Syrigos K
Fertil Steril . 2009 Sep; 94(2):558-63. PMID: 19765702
Objective: To assess the effects of taxane-based chemotherapy on the male reproductive axis, and, therefore, its impact on spermatogenesis and fertility. Design: Controlled clinical study. Setting: Patients with cancer in...
4.
Stergiou G, Alamara C, Drakatos A, Stefanidis C, Vazeou A
Hypertens Res . 2009 Jun; 32(8):680-4. PMID: 19498440
In type 1 diabetes, the risk of nephropathy is strongly influenced by the level of blood pressure (BP). Ambulatory BP (ABP) monitoring has revealed an association between disturbed nocturnal BP...
5.
Karapanagiotou E, Terpos E, Dilana K, Alamara C, Gkiozos I, Polyzos A, et al.
Med Oncol . 2009 Apr; 27(2):332-8. PMID: 19373566
The aim of this study was to investigate several bone markers in Non-Small Cell Lung (NSCLC) and Small Cell Lung (SCLC) patients experiencing or not secondary bony disease. Fasting serum...
6.
Alamara C, Karapanagiotou E, Tourkantonis I, Xyla V, Maurer C, Lykourinas M, et al.
Eur J Intern Med . 2008 Nov; 19(7):e67-9. PMID: 19013370
No abstract available.
7.
Stergiou G, Christodoulakis G, Giovas P, Lourida P, Alamara C, Roussias L
Am J Hypertens . 2008 Apr; 21(6):633-8. PMID: 18443574
Objective: To investigate the minimum schedule of blood pressure (BP) measurements necessary to provide a reliable assessment of home BP (HBP) in children and adolescents. Methods: Subjects aged 6-18 years...
8.
Kotteas E, Alamara C, Kiagia M, Pantazopoulos K, Boufas A, Provata A, et al.
Anticancer Res . 2008 Apr; 28(1B):529-33. PMID: 18383897
Zoledronic acid (Zometa, Novartis, Basel, Switzerland) is a new generation of bisphosphonates (BPs) with demonstrated clinical benefit in breast and prostate cancer patients with bone metastases. The safety and efficacy...
9.
Karapanagiotou E, Saif M, Rondoyianni D, Markaki S, Alamara C, Kiagia M, et al.
Yale J Biol Med . 2007 Oct; 79(3-4):165-8. PMID: 17940626
Although metastases within the thyroid gland are rare, they are not as infrequent as generally believed. Asymptomatic breast, lung, and renal cell carcinomas may metastasize to the thyroid. When they...
10.
Tzannou I, Karapanagiotou E, Charpidou A, Dilana K, Alamara C, Christakopoulou I, et al.
Am J Clin Oncol . 2007 Oct; 30(5):503-6. PMID: 17921711
Objectives: The prognosis of patients with small cell lung cancer (SCLC) is dismal with a median survival not exceeding 18 months. For the fact that the tumor stage remains the...